Posttranscriptional deregulation of Src due to aberrant miR34a and miR203 contributes to gastric cancer development
1
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Gastric cancer remains the main cause of cancer death all around the world, and upregulated activation of the nonreceptor tyrosine kinase c-SRC (SRC) is a key player in the development. In this study, we found that expression of Src is also increased in clinical gastric cancer samples, with the protein level increased more significantly than that at the RNA level. Further study revealed that miR34a and miR203, two tumor suppressive miRNAs, inversely correlate with the expression of Src. Restoration of miR34a and miR203 decreased Src expression in gastric cancer cell lines, which in turn inhibited cell growth and cell migration. In summary, our study here revealed that posttranscriptional regulation of Src contributes to the deregulated cell growth and metastasis in gastric cancer, and targeting Src by miR34a or miR203 mimics would be a promising strategy in therapy.
Abstract
Gastric cancer remains the main cause of cancer death all around the world, and upregulated activation of the nonreceptor tyrosine kinase c-SRC (SRC) is a key player in the development. In this study, we found that expression of Src is also increased in clinical gastric cancer samples, with the protein level increased more significantly than that at the RNA level. Further study revealed that miR34a and miR203, two tumor suppressive miRNAs, inversely correlate with the expression of Src. Restoration of miR34a and miR203 decreased Src expression in gastric cancer cell lines, which in turn inhibited cell growth and cell migration. In summary, our study here revealed that posttranscriptional regulation of Src contributes to the deregulated cell growth and metastasis in gastric cancer, and targeting Src by miR34a or miR203 mimics would be a promising strategy in therapy.
참고문헌 (24)
- Siegel, R., "Cancer statistics, 2012", CA Cancer J. Clin, 62, pp.10~29 (2012)
- Le, X. F, "Src family kinases and paclitaxel sensitivity", Cancer Biol. Ther, 12, pp.260~269 (2011)
- Aleshin, A., "SRC : a century of science brought to the clinic", Neoplasia, 12, pp.599~607 (2010)
- Wheeler, D. L., "The role of Src in solid tumors", Oncologist, 14, pp.667~678 (2009)
- Ishizawar, R., "c-Src and cooperating partners in human cancer", Cancer Cell, 6, pp.209~214 (2004)
- Yang, G., "RNA-binding protein quaking, a critical regulator of colon epithelial differentiation and a suppressor of colon cancer", Gastroenterology, 138, pp.231~240 (2010)
- Wightman, B., "Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans", Cell, 75, pp.855~862 (1993)
- Lee, R. C., "The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14", Cell, 75, pp.843~854 (1993)
- Bartel, D. P., "MicroRNAs : genomics, biogenesis, mechanism, and function", Cell, 116, pp.281~297 (2004)
- Calin, G. A., "MicroRNA signatures in human cancers", Nat. Rev. Cancer, 6, pp.857~866 (2006)
- Esquela-Kerscher, A., "Oncomirs - microRNAs with a role in cancer", Nat. Rev. Cancer, 6, pp.259~269 (2006)
- Kato, M., "The mir-34 microRNA is required for the DNA damage response in vivo in C. elegans and in vitro in human breast cancer cells", Oncogene, 28, pp.2419~2424 (2009)
- Roy, S., "Expression of miR-34 is lost in colon cancer which can be re-expressed by a novel agent CDF", J. Hematol. Oncol, 5, pp.58~ (2012)
- Kasinski, A. L., "miRNA-34 prevents cancer initiation and progression in a therapeutically-resistant K-ras and p53-induced mouse model of lung adenocarcinoma", Cancer Res, 72, pp.5576~5587 (2012)
- Wang, C., "MicroRNA- 203 suppresses cell proliferation and migration by targeting BIRC5 and LASP1 in human triple-negative breast cancer cells", J. Exp. Clin. Cancer Res, 31, pp.58~ (2012)
- Summy, J. M., "Src family kinases in tumor progression and metastasis", Cancer Metastasis Rev, 22, pp.337~358 (2003)
- Okamoto, W., "Identification of c-Src as a potential therapeutic target for gastric cancer and of MET activation as a cause of resistance to c-Src inhibition", Mol. Cancer Ther, 9, pp.1188~1197 (2010)
- Grimson, A., "MicroRNA targeting specificity in mammals: determinants beyond seed pairing", Mol. Cell, 27, pp.91~105 (2007)
- Garofalo, M., "EGFR and MET receptor tyrosine kinase-altered microRNA expression induces tumorigenesis and gefitinib resistance in lung cancers", Nat. Med, 18, pp.74~82 (2012)
- Saini, S., "Curcumin modulates microRNA-203-mediated regulation of the Src-Akt axis in bladder cancer", Cancer Prev. Res. (Phila), 4, pp.1698~1709 (2011)
- Li, N., "Increased miR-222 in H. pylori-associated gastric cancer correlated with tumor progression by promoting cancer cell proliferation and targeting RECK", FEBS Lett, 586, pp.722~728 (2012)
- Zauli, G., "miR-34a induces the downregulation of both E2F1 and B-Myb oncogenes in leukemic cells", Clin. Cancer Res, 17, pp.2712~2724 (2011)
- Yang, G., "E2F1 and RNA binding protein QKI comprise a negative feedback in the cell cycle regulation", Cell Cycle, 10, pp.2703~2713 (2011)
- Oukka, M., "Schnurri-3 (KRC) interacts with c-Jun to regulate the IL-2 gene in T cells", J. Exp. Med, 199, pp.15~24 (2004)